Implitapide

DRUG3 trials

Sponsors

Medical Research Laboratories International

Conditions

Familial HypercholesterolemiaHypertriglyceridemia

Phase 2

Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy

TerminatedNCT00079859

Medical Research Laboratories InternationalFamilial Hypercholesterolemia

Start: 2003-10-31End: 2005-04-30Target: 120Updated: 2005-06-24

Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy

TerminatedNCT00079846

Medical Research Laboratories InternationalFamilial Hypercholesterolemia

Start: 2003-09-30End: 2005-04-30Target: 60Updated: 2005-06-24

Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy

TerminatedNCT00080132

Medical Research Laboratories InternationalHypertriglyceridemia

Start: 2004-10-31End: 2005-04-30Target: 50Updated: 2005-06-24